Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
Approximately 100–400 million people from more than 100 countries in the tropical and subtropical world are affected by dengue infections. Recent scientific breakthroughs have brought new insights into novel strategies for the production of dengue antivirals and vaccines. The search for specific den...
| Published in: | Molecules |
|---|---|
| Main Authors: | Harun Norshidah, Ramachandran Vignesh, Ngit Shin Lai |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-11-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/26/22/6768 |
Similar Items
Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach
by: Harun Norshidah, et al.
Published: (2023-02-01)
by: Harun Norshidah, et al.
Published: (2023-02-01)
Dengue virus NS4B protein as a target for developing antivirals
by: Qingxin Li, et al.
Published: (2022-08-01)
by: Qingxin Li, et al.
Published: (2022-08-01)
The Antiviral Activity of Varenicline against Dengue Virus Replication during the Post-Entry Stage
by: Ching-Lin Lin, et al.
Published: (2023-10-01)
by: Ching-Lin Lin, et al.
Published: (2023-10-01)
Lambda-free light chain: A serum marker of dengue disease via NS3 protease-mediated antibody cleavage
by: Sheng-Hsuan Wang, et al.
Published: (2023-12-01)
by: Sheng-Hsuan Wang, et al.
Published: (2023-12-01)
Antiviral Activity of an Indole-Type Compound Derived from Natural Products, Identified by Virtual Screening by Interaction on Dengue Virus NS5 Protein
by: Leidy Lorena García-Ariza, et al.
Published: (2023-07-01)
by: Leidy Lorena García-Ariza, et al.
Published: (2023-07-01)
In Silico Prediction of the Phosphorylation of NS3 as an Essential Mechanism for Dengue Virus Replication and the Antiviral Activity of Quercetin
by: Lamya Alomair, et al.
Published: (2021-10-01)
by: Lamya Alomair, et al.
Published: (2021-10-01)
Current Trends and Limitations in Dengue Antiviral Research
by: Juliet O. Obi, et al.
Published: (2021-09-01)
by: Juliet O. Obi, et al.
Published: (2021-09-01)
Evaluation of dengue NS1 antigen detection for diagnosis in public health laboratories, São Paulo State, 2009
by: Ivani Bisordi, et al.
Published: (2011-12-01)
by: Ivani Bisordi, et al.
Published: (2011-12-01)
Novel Thiazolidinedione Derivatives as Potential ZIKV Antiviral Inhibitors
by: Isabella Luiza Ralph de Oliveira, et al.
Published: (2025-08-01)
by: Isabella Luiza Ralph de Oliveira, et al.
Published: (2025-08-01)
Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication
by: Jenny Kouretova, et al.
Published: (2017-01-01)
by: Jenny Kouretova, et al.
Published: (2017-01-01)
Paritaprevir as a pan-antiviral against different flaviviruses
by: R. P. Yadav, et al.
Published: (2025-04-01)
by: R. P. Yadav, et al.
Published: (2025-04-01)
Coatomer protein complex I is required for efficient secretion of dengue virus non-structural protein 1
by: Stephen M. Johnson, et al.
Published: (2025-09-01)
by: Stephen M. Johnson, et al.
Published: (2025-09-01)
A Computational Approach Applied to the Study of Potential Allosteric Inhibitors Protease NS2B/NS3 from Dengue Virus
by: Renato A. da Costa, et al.
Published: (2022-06-01)
by: Renato A. da Costa, et al.
Published: (2022-06-01)
Diagnostic Performance of Dengue NS1 and Antibodies by Serum Concentration Technique
by: Viravarn Luvira, et al.
Published: (2023-02-01)
by: Viravarn Luvira, et al.
Published: (2023-02-01)
New dengue virus inhibitors targeting NS3-NS5 interaction identified by in silico screening
by: Giulio Nannetti, et al.
Published: (2025-10-01)
by: Giulio Nannetti, et al.
Published: (2025-10-01)
Patogénesis de la enfermedad por virus del dengue. Revisión de la literatura
by: Josué Beita Jiménez, et al.
Published: (2016-05-01)
by: Josué Beita Jiménez, et al.
Published: (2016-05-01)
Molecular Docking and Pharmacokinetics Analysis of Phytochemicals from Piper caninum as Dengue NS2B-NS3 Protease Inhibitors
by: Nur Farhana Mustafa, et al.
Published: (2024-02-01)
by: Nur Farhana Mustafa, et al.
Published: (2024-02-01)
Identification of Potential Inhibitors Targeting Non-Structural Proteins NS3 and NS5 of Dengue Virus Using Docking and Deep Learning Approaches
by: Alomgir Hossain, et al.
Published: (2025-04-01)
by: Alomgir Hossain, et al.
Published: (2025-04-01)
Dengue Infection - Prevalence and Seasonal Variation Among Patients Attending a Tertiary Care Hospital at Lower Himalayan Region, India
by: Natasha Sawhney, et al.
Published: (2023-04-01)
by: Natasha Sawhney, et al.
Published: (2023-04-01)
Computational design and in vitro assay of lantadene-based novel inhibitors of NS3 protease of dengue virus
by: Mujwar Somdutt, et al.
Published: (2024-03-01)
by: Mujwar Somdutt, et al.
Published: (2024-03-01)
Dengue encephalitis–A rare manifestation of dengue fever
by: Deepak Madi, et al.
Published: (2014-05-01)
by: Deepak Madi, et al.
Published: (2014-05-01)
Investigação de polimorfismos no genoma do vírus da Dengue
by: Roberto Fabian Santos de Araújo, et al.
Published: (2007-12-01)
by: Roberto Fabian Santos de Araújo, et al.
Published: (2007-12-01)
Dengue Virus Glycosylation: What Do We Know?
by: Sally S. L. Yap, et al.
Published: (2017-07-01)
by: Sally S. L. Yap, et al.
Published: (2017-07-01)
Characterization of dengue cases among patients with an acute illness, Central Department, Paraguay
by: Alejandra Rojas, et al.
Published: (2019-10-01)
by: Alejandra Rojas, et al.
Published: (2019-10-01)
Identification of Key Residues in Dengue Virus NS1 Protein That Are Essential for Its Secretion
by: Brandon E. K. Tan, et al.
Published: (2023-04-01)
by: Brandon E. K. Tan, et al.
Published: (2023-04-01)
In silico testing of flavonoids as potential inhibitors of protease and helicase domains of dengue and Zika viruses
by: Omar Cruz-Arreola, et al.
Published: (2022-08-01)
by: Omar Cruz-Arreola, et al.
Published: (2022-08-01)
Releasing Intracellular NS1 from Mosquito Cells for the Detection of Dengue Virus-Infected Mosquitoes
by: Lie Cheng, et al.
Published: (2020-09-01)
by: Lie Cheng, et al.
Published: (2020-09-01)
Demographic and clinical features of dengue fever infection in Pakistan: a cross-sectional epidemiological study
by: Tanzeel Zohra, et al.
Published: (2024-04-01)
by: Tanzeel Zohra, et al.
Published: (2024-04-01)
Design, Synthesis, Evaluation and Molecular Dynamics Simulation of Dengue Virus NS5-RdRp Inhibitors
by: Keli Zong, et al.
Published: (2023-11-01)
by: Keli Zong, et al.
Published: (2023-11-01)
Molecular Docking and Pharmacophore Analysis of Compounds from Ginger (Zingiber officinale) as Inhibitor for Dengue DEN2 NS2B/NS3 Serine Protease
by: Neni Frimayanti, et al.
Published: (2023-09-01)
by: Neni Frimayanti, et al.
Published: (2023-09-01)
A REVIEW ON FUTURE PERSPECTIVES IN TARGETING THE RNA CAPPING IN DENGUE VIRUS BY NS5 METHYLTRANSFERASE
by: Kapil Vashisht, et al.
Published: (2023-04-01)
by: Kapil Vashisht, et al.
Published: (2023-04-01)
Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
by: Subodh K. Samrat, et al.
Published: (2022-02-01)
by: Subodh K. Samrat, et al.
Published: (2022-02-01)
A fast-growing dengue virus mutant reveals a dual role of STING in response to infection
by: Wy Ching Ng, et al.
Published: (2022-12-01)
by: Wy Ching Ng, et al.
Published: (2022-12-01)
Development of a luminescence-based method for measuring West Nile Virus MTase activity and its application to screen for antivirals
by: Alejandra Álvarez-Mínguez, et al.
Published: (2024-01-01)
by: Alejandra Álvarez-Mínguez, et al.
Published: (2024-01-01)
Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study
by: Rasel Ahmed Khan, et al.
Published: (2021-11-01)
by: Rasel Ahmed Khan, et al.
Published: (2021-11-01)
Clinical Performance of MAGLUMI Diagnostic Tests for the Automated Detection of Dengue Virus
by: Bo Peng, et al.
Published: (2025-01-01)
by: Bo Peng, et al.
Published: (2025-01-01)
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo
by: Marta Celegato, et al.
Published: (2023-02-01)
by: Marta Celegato, et al.
Published: (2023-02-01)
Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study
by: Mst. Sharmin Sultana Shimu, et al.
Published: (2022-01-01)
by: Mst. Sharmin Sultana Shimu, et al.
Published: (2022-01-01)
Recent advances on pathogenesis, diagnosis, prevention, immunological aspects, and vectors of dengue: A review
by: Mahesh Chandra Sahu, et al.
Published: (2023-01-01)
by: Mahesh Chandra Sahu, et al.
Published: (2023-01-01)
Dengue NS1 interaction with lipids alters its pathogenic effects on monocyte derived macrophages
by: Shashika Dayarathna, et al.
Published: (2024-09-01)
by: Shashika Dayarathna, et al.
Published: (2024-09-01)
Similar Items
-
Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach
by: Harun Norshidah, et al.
Published: (2023-02-01) -
Dengue virus NS4B protein as a target for developing antivirals
by: Qingxin Li, et al.
Published: (2022-08-01) -
The Antiviral Activity of Varenicline against Dengue Virus Replication during the Post-Entry Stage
by: Ching-Lin Lin, et al.
Published: (2023-10-01) -
Lambda-free light chain: A serum marker of dengue disease via NS3 protease-mediated antibody cleavage
by: Sheng-Hsuan Wang, et al.
Published: (2023-12-01) -
Antiviral Activity of an Indole-Type Compound Derived from Natural Products, Identified by Virtual Screening by Interaction on Dengue Virus NS5 Protein
by: Leidy Lorena García-Ariza, et al.
Published: (2023-07-01)
